thiotepa has been researched along with Duncan Disease in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-one consecutive patients with acute myelogenous leukemia (AML) in first complete remission and 8 with AML in second complete remission received T cell-depleted allogeneic bone marrow transplants from HLA-identical sibling donors." | 1.30 | T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. ( Black, PM; Bleau, SA; Boulad, F; Carabasi, MH; Castro-Malaspina, H; Childs, BH; Collins, NH; Gillio, AP; Heller, G; Kernan, NA; Mackinnon, S; O'Reilly, RJ; Papadopoulos, EB; Small, TN; Szabolcs, P; Taylor, J; Yahalom, J; Young, JW, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadopoulos, EB | 1 |
| Carabasi, MH | 1 |
| Castro-Malaspina, H | 1 |
| Childs, BH | 1 |
| Mackinnon, S | 1 |
| Boulad, F | 1 |
| Gillio, AP | 1 |
| Kernan, NA | 1 |
| Small, TN | 1 |
| Szabolcs, P | 1 |
| Taylor, J | 1 |
| Yahalom, J | 1 |
| Collins, NH | 1 |
| Bleau, SA | 1 |
| Black, PM | 1 |
| Heller, G | 1 |
| O'Reilly, RJ | 1 |
| Young, JW | 1 |
| Raiola, AM | 1 |
| Van Lint, MT | 1 |
| Lamparelli, T | 1 |
| Gualandi, F | 1 |
| Mordini, N | 1 |
| Berisso, G | 1 |
| Bregante, S | 1 |
| Frassoni, F | 1 |
| Sessarego, M | 1 |
| Fugazza, G | 1 |
| Di Stefano, F | 1 |
| Pitto, A | 1 |
| Bacigalupo, A | 1 |
2 other studies available for thiotepa and Duncan Disease
| Article | Year |
|---|---|
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Marrow Purging; Bone Marrow Transplantati | 1998 |
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
Topics: Adult; Antineoplastic Agents, Alkylating; Cyclophosphamide; Drug Administration Schedule; Female; Fo | 2000 |